Literature DB >> 12419200

Immunoglobulin genes: generating diversity with AID and UNG.

Ursula Storb1, Janet Stavnezer.   

Abstract

Somatic hypermutation and switch recombination of immunoglobulin genes require the activity of the activation-induced deaminase, AID. Recent studies of mice deficient for the uracil-DNA glycosylase UNG, which removes U from DNA, suggest that AID catalyses the deamination of dC to dU during antibody diversification.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419200     DOI: 10.1016/s0960-9822(02)01247-2

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  24 in total

1.  Germinal center-associated nuclear protein contributes to affinity maturation of B cell antigen receptor in T cell-dependent responses.

Authors:  Kazuhiko Kuwahara; Satoru Fujimura; Yoshimasa Takahashi; Naomi Nakagata; Toshitada Takemori; Shinichi Aizawa; Nobuo Sakaguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-08       Impact factor: 11.205

2.  Known components of the immunoglobulin A:T mutational machinery are intact in Burkitt lymphoma cell lines with G:C bias.

Authors:  Zheng Xiao; Madhumita Ray; Chuancang Jiang; Alan B Clark; Igor B Rogozin; Marilyn Diaz
Journal:  Mol Immunol       Date:  2007-01-22       Impact factor: 4.407

3.  Activation-induced cytidine deaminase-initiated off-target DNA breaks are detected and resolved during S phase.

Authors:  Muneer G Hasham; Kathy J Snow; Nina M Donghia; Jane A Branca; Mark D Lessard; Janet Stavnezer; Lindsay S Shopland; Kevin D Mills
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

4.  A high-resolution landscape of mutations in the BCL6 super-enhancer in normal human B cells.

Authors:  Jiang-Cheng Shen; Ashwini S Kamath-Loeb; Brendan F Kohrn; Keith R Loeb; Bradley D Preston; Lawrence A Loeb
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-20       Impact factor: 11.205

5.  Mutations occur in the Ig Smu region but rarely in Sgamma regions prior to class switch recombination.

Authors:  Carol E Schrader; Sean P Bradley; Joycelyn Vardo; Sofia N Mochegova; Erin Flanagan; Janet Stavnezer
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

6.  Novel antibody switching defects in human patients.

Authors:  John P Manis; Frederick W Alt
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled.

Authors:  Hong Ming Shen; Ursula Storb
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-24       Impact factor: 11.205

8.  RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells.

Authors:  Tomonori Eto; Kazuo Kinoshita; Kiyotsugu Yoshikawa; Masamichi Muramatsu; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-14       Impact factor: 11.205

Review 9.  Why does cytotoxic chemotherapy cure only some cancers?

Authors:  Philip Savage; Justin Stebbing; Mark Bower; Tim Crook
Journal:  Nat Clin Pract Oncol       Date:  2008-11-04

10.  Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region.

Authors:  Wesley A Dunnick; John T Collins; Jian Shi; Gerwin Westfield; Clinton Fontaine; Paul Hakimpour; F Nina Papavasiliou
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.